Download Unicorn Signals App

Powered By EquityPandit
Latest News

Lupin launches Desoximetasone Topical Spray, in US market

Lupin has launched Desoximetasone Topical Spray, in the US market. It is used for treatment of plaque psoriasis.

In a regulatory filing the company stated, “Lupin’s Desoximetasone Topical Spray, 0.25%, is the generic equivalent of Taro Pharmaceuticals USA Inc.’s Topicort Topical Spray, 0.25%. It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.”

Read EquityPandit’s Technical Analysis of Lupin

 

Get Daily Prediction & Stocks Tips On Your Mobile